Comparing outcomes of treatments with ETRANS-based electrical stimulation versus electrical phosphene stimulation in patients with accommodative dysfunction by Shakir Dukhayer, N.M. Bushuyeva, V.S. Ponomarchuk, N.I. Khramenko

Subjects: Get full text

Efficacy of complex neuroprotection in glaucomatous optic neuropathy by O.V. Guzun, N.I. Khramenko, S.B. Slobodianyk, V.S. Ponomarchuk, O.A. Peretyagin

“…A combined treatment including LS of the optic nerve and the papillomacular bundle followed by a six-month vitamin and antioxidant supplement therapy with resveratrol (1 mg) in patients with glaucomatous optical neuropathy contributes to: an increase in visual acuity by 26%; an increase in the visual system sensitivity, evidenced by a decrease of phosphene threshold current by 10%; an improvement in ocular blood flow by 8%; a decrease of intraocular vasospasm by 18%; and a significant decrease in overall retinal light sensitivity by 23%. …”
Get full text

Regional and central hemodynamics in ischemic optic neuropathy by N.I. Khramenko, N.V. Konovalova, O.V. Guzun

“…Patients underwent assessment of visual acuity, ophthalmoscopy, biomicroscopy, perimetry, intraocular pressure (IOP) and systemic blood pressure measurements, examination of the electrical sensitivity of the optic nerve and critical frequency of phosphene disappearance, ophthalmic rheography (ORG) and rheoencephalography (REG). …”
Get full text